Disclosure of financial relationships |
145 (89%) |
Of author(s)
|
145 (89) |
Of author’s institution
|
40 (25) |
Of author’s family member(s)
|
17 (10) |
Not explicitly required
|
18 (11) |
Of other
|
1 (0) |
Types of financial disclosure |
Stock ownership
|
83 (51) |
Grant/research support
|
73 (45) |
Direct employment
|
73 (45) |
Serving as an advisor, consultant, or public advocate
|
70 (43) |
Honoraria for speaking, writing, or reviewing on the topic discussed in the manuscript
|
53 (33) |
Personal fees
|
50 (31) |
Indirect financial support
|
47 (29) |
Speaker bureaus or board membership
|
37 (23) |
Royalties
|
26 (16) |
Other type of financial COI
|
4 (3) |
Required but did not specify which types of financial COI
|
40 (25) |
Not required
|
28 (17) |
Duration for which to disclose financial COI |
Not specified
|
142 (87) |
Yes, for the previous number of months
|
20 (12) |
Yes, irrespective of timing (i.e., at any time)
|
1 (1) |
Number of months of required duration (N = 20) |
Within 12 months
|
0 (0) |
12 months
|
0 (0) |
24 months
|
1 (5) |
36 months
|
18 (90) |
4 years
|
0 (0) |
5 years
|
1 (5) |
> 5 years
|
0 (0) |
Time frame for financial COI disclosure |
Time of the submission
|
11 (7) |
At the initiation of the study
|
5 (3) |
Not specified
|
4 (3) |
Required disclosure of financial COI in the near future |
12 (7) |
Required duration of financial COI outside submitted work |
1 (0) |
Explicitly required source of financial benefit |
64 (39) |
Required monetary value of financial benefit |
Not required
|
162 (100) |
Yes, irrespective of amount
|
1 (0) |
Yes, for amounts above a specific value
|
0 (0) |
Required disclosure of any patents |
63 (41) |